Show simple item record

dc.contributor.authorKelly, H
dc.contributor.authorCarville, K
dc.contributor.authorGrant, K
dc.contributor.authorJacoby, P
dc.contributor.authorTran, T
dc.contributor.authorBarr, I
dc.date.accessioned2020-12-17T02:44:41Z
dc.date.available2020-12-17T02:44:41Z
dc.date.issued2009
dc.identifier.citationKelly, H., Carville, K., Grant, K., Jacoby, P., Tran, T. & Barr, I. (2009). Estimation of influenza vaccine effectiveness from routine surveillance data.. PLoS One, 4 (3), pp.e5079-. https://doi.org/10.1371/journal.pone.0005079.
dc.identifier.issn1932-6203
dc.identifier.urihttp://hdl.handle.net/11343/254632
dc.description.abstractBACKGROUND: Influenza vaccines are reviewed each year, and often changed, in an effort to maintain their effectiveness against drifted influenza viruses. There is however no regular review of influenza vaccine effectiveness during, or at the end of, Australian influenza seasons. It is possible to use a case control method to estimate vaccine effectiveness from surveillance data when all patients in a surveillance system are tested for influenza and their vaccination status is known. METHODOLOGY/PRINCIPAL FINDINGS: Influenza-like illness (ILI) surveillance is conducted during the influenza season in sentinel general practices scattered throughout Victoria, Australia. Over five seasons 2003-7, data on age, sex and vaccination status were collected and nose and throat swabs were offered to patients presenting within three days of the onset of their symptoms. Swabs were tested using a reverse transcriptase polymerase chain reaction (RT-PCR) test. Those positive for influenza were sent to the World Health Organization (WHO) Collaborating Centre for Reference and Research on Influenza where influenza virus culture and strain identification was attempted. We used a retrospective case control design in five consecutive influenza seasons, and estimated influenza vaccine effectiveness (VE) for patients of all ages to be 53% (95% CI 38-64), but 41% (95% CI 19-57) adjusted for age group and year. The adjusted VE for all adults aged at least 20 years, the age groups for whom a benefit of vaccination could be shown, was 51% (95% CI 34-63). Comparison of VE estimates with vaccine and circulating strain matches across the years did not reveal any significant differences. CONCLUSIONS/SIGNIFICANCE: These estimates support other field studies of influenza vaccine effectiveness, given that theoretical considerations suggest that these values may underestimate true effectiveness, depending on test specificity and the ratio of the influenza ILI attack rate to the non-influenza ILI attack rate. Incomplete recording of vaccination status and under-representation of children in patients from whom a swab was collected limit the data. Improvements have been implemented for prospective studies.
dc.languageeng
dc.publisherPublic Library of Science (PLoS)
dc.titleEstimation of influenza vaccine effectiveness from routine surveillance data.
dc.typeJournal Article
dc.identifier.doi10.1371/journal.pone.0005079
melbourne.affiliation.departmentMicrobiology and Immunology
melbourne.source.titlePLoS One
melbourne.source.volume4
melbourne.source.issue3
melbourne.source.pagese5079-
dc.rights.licenseCC BY
melbourne.elementsid1219077
melbourne.openaccess.pmchttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC2658741
melbourne.contributor.authorBarr, Ian
dc.identifier.eissn1932-6203
melbourne.accessrightsOpen Access


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record